Cargando…
Long non‐coding RNA NORAD promotes the prostate cancer cell extracellular vesicle release via microRNA-541-3p-regulated PKM2 to induce bone metastasis of prostate cancer
BACKGROUND: Bone metastasis is the leading cause of mortality and reduced quality of life in patients with metastatic prostate cancer (PCa). Long non-coding RNA activated by DNA damage (NORAD) has been observed to have an abnormal expression in various cancers. This article aimed to explore the mole...
Autores principales: | Hu, Chuan-yi, Chen, Juan, Qin, Xin-hua, You, Pan, Ma, Jie, Zhang, Jing, Zhang, He, Xu, Ji-dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962263/ https://www.ncbi.nlm.nih.gov/pubmed/33722248 http://dx.doi.org/10.1186/s13046-021-01891-0 |
Ejemplares similares
-
Long non-coding RNA NORAD induces cell proliferation and migration in prostate cancer
por: Zhang, Haiyan, et al.
Publicado: (2019) -
A microRNA code for prostate cancer metastasis
por: Bonci, D, et al.
Publicado: (2016) -
A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer
por: Fletcher, C. E., et al.
Publicado: (2022) -
MicroRNA-122 regulates docetaxel resistance of prostate cancer cells by regulating PKM2
por: Zhu, Zhirong, et al.
Publicado: (2020) -
Diagnostic implications of lncRNA NORAD in breast cancer
por: Zhang, Yaping, et al.
Publicado: (2023)